Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$0.76 AUD
Change Today -0.005 / -0.65%
Volume 3.2K
As of 8:27 PM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

starpharma holdings ltd (SPL) Snapshot

Open
A$0.76
Previous Close
A$0.77
Day High
A$0.76
Day Low
A$0.76
52 Week High
07/23/14 - A$0.99
52 Week Low
12/16/14 - A$0.41
Market Cap
242.5M
Average Volume 10 Days
388.5K
EPS TTM
A$-0.06
Shares Outstanding
319.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for STARPHARMA HOLDINGS LTD (SPL)

Related News

No related news articles were found.

starpharma holdings ltd (SPL) Related Businessweek News

No Related Businessweek News Found

starpharma holdings ltd (SPL) Details

Starpharma Holdings Limited researches, develops, and commercializes dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia. The company focuses on the development of VivaGel, a microbicidal agent in Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for prevention of sexual transmitted infections. It also develops dendrimer-enhanced, or DEP versions of existing drugs, including DEP docetaxel in Phase I clinical trial for breast, prostate, lung, and ovarian tumor; and agrochemicals. Starpharma Holdings Limited was founded in 1996 and is headquartered in Abbotsford, Australia.

Founded in 1996

starpharma holdings ltd (SPL) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: A$603.6K
Chief Financial Officer and Company Secretary
Total Annual Compensation: A$222.6K
Vice President of Development & Regulatory Af...
Total Annual Compensation: A$237.2K
Vice President of Business Development
Total Annual Compensation: A$237.1K
Vice President of Research
Total Annual Compensation: A$236.8K
Compensation as of Fiscal Year 2014.

starpharma holdings ltd (SPL) Key Developments

Starpharma Holdings Limited to Report Q3, 2015 Results on Apr 30, 2015

Starpharma Holdings Limited announced that they will report Q3, 2015 results on Apr 30, 2015

Starpharma Holdings Limited Announces Consolidated Cash Flows Results for Fourth Quarter and Year Ended March 31, 2015

Starpharma Holdings Limited announced consolidated cash flows results for fourth quarter and year ended March 31, 2015. For the quarter, the company reported net operating cash flows of AUD 4,707,000 and payment for acquisition businesses, equity investments, intellectual property, physical non-current assets and other non-current assets of AUD 207,000. For the year, the company reported net operating cash flows of AUD 9,832,000 and payment for acquisition businesses, equity investments, intellectual property, physical non-current assets and other non-current assets of AUD 640,000 last year.

Starpharma Holdings Limited Presents at ASX Spotlight Conference 2015, Mar-05-2015 09:25 AM

Starpharma Holdings Limited Presents at ASX Spotlight Conference 2015, Mar-05-2015 09:25 AM. Venue: Le Parker Meridien, New York, New York, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SPL:AU A$0.76 AUD -0.005

SPL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SPL.
View Industry Companies
 

Industry Analysis

SPL

Industry Average

Valuation SPL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 173.3x
Price/Book 5.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 152.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STARPHARMA HOLDINGS LTD, please visit www.starpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.